Eagle’s Eye View: What is the Safety and Tolerability of Inclisiran in Treating Hypercholesterolemia?

In this week’s View, Dr. Eagle explores longitudinal changes in pulmonary artery pressure late in life using data from the ARIC study. He then discusses the safety and tolerability of inclisiran for treatment of hypercholesterolemia. Finally, Dr. Eagle asses late gadolinium enhancement in hypertrophic cardiomyopathy and how it improves risk stratification based on current guidelines. 

Subscribe to Eagle’s Eye View